Metropolis Healthcare informs about disclosure

07 Apr 2025 Evaluate
Pursuant to Regulation 30 of the Listing Regulations, Metropolis Healthcare has informed that the Metropolis Histoxpert Digital Services (‘Metropolis Histoxpert’), a wholly owned subsidiary of the Company, has entered into Business Transfer Agreement (‘BTA’) on Monday, April 07, 2025, with Dr. Ahujas’ Pathology & Imaging Centre (DAPIC – a partnership firm), Dr. Alok Ahuja and Dr. Alka Ahuja for the acquisition of their entire business as a going concern on a slump sale basis. The completion of the business acquisition is contingent upon the fulfillment of the condition’s precedent outlined in the BTA. The details as required under the Listing Regulations are provided in ‘Annexure A’ with this intimation.

The above information is a part of company’s filings submitted to BSE.

Metropolis Health. Share Price

430.10 -0.95 (-0.22%)
30-Mar-2026 12:32 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7425.65
Max Healthcare Inst 961.60
Narayana Hrudayalay 1618.25
Aster DM Healthcare 653.35
Global Health 976.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×